X-154381042-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_000117.3(EMD):​c.610C>T​(p.Arg204Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000014 in 1,210,803 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R204H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000014 ( 0 hom. 1 hem. )

Consequence

EMD
NM_000117.3 missense

Scores

2
5
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: 1.09

Publications

1 publications found
Variant links:
Genes affected
EMD (HGNC:3331): (emerin) Emerin is a serine-rich nuclear membrane protein and a member of the nuclear lamina-associated protein family. It mediates membrane anchorage to the cytoskeleton. Dreifuss-Emery muscular dystrophy is an X-linked inherited degenerative myopathy resulting from mutation in the emerin gene. [provided by RefSeq, Jul 2008]
EMD Gene-Disease associations (from GenCC):
  • X-linked Emery-Dreifuss muscular dystrophy
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • heart conduction disease
    Inheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21084535).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EMDNM_000117.3 linkc.610C>T p.Arg204Cys missense_variant Exon 6 of 6 ENST00000369842.9 NP_000108.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EMDENST00000369842.9 linkc.610C>T p.Arg204Cys missense_variant Exon 6 of 6 1 NM_000117.3 ENSP00000358857.4

Frequencies

GnomAD3 genomes
AF:
0.0000177
AC:
2
AN:
112733
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000322
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000218
AC:
4
AN:
183163
AF XY:
0.0000148
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000367
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.0000137
AC:
15
AN:
1098070
Hom.:
0
Cov.:
32
AF XY:
0.00000275
AC XY:
1
AN XY:
363492
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26403
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19386
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.0000369
AC:
2
AN:
54148
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.0000142
AC:
12
AN:
842133
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46091
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000177
AC:
2
AN:
112733
Hom.:
0
Cov.:
23
AF XY:
0.00
AC XY:
0
AN XY:
34881
show subpopulations
African (AFR)
AF:
0.0000322
AC:
1
AN:
31016
American (AMR)
AF:
0.00
AC:
0
AN:
10746
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3605
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2757
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6277
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
238
European-Non Finnish (NFE)
AF:
0.0000188
AC:
1
AN:
53237
Other (OTH)
AF:
0.00
AC:
0
AN:
1520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Emery-Dreifuss muscular dystrophy Uncertain:1
Sep 16, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Emery-Dreifuss muscular dystrophy 1, X-linked Uncertain:1
Jul 13, 2021
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Dec 10, 2012
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Arg204Cys c.610 CGT>TGT in exon 6 of the EMD gene (NM_000117.2): The Arg204Cys variant in the EMD gene has not been reported as a disease-causing mutation or as a benign polymorphism to our knowledge. The NHLBI ESP Exome Variant Server reports Arg204Cys was not observed in approximately 6,300 samples from individuals of European and African American backgrounds, indicating it is not a common benign variant in these populations. Arg204Cys results in a semi-conservative amino acid substitution of a positively charged Arginine residue with a neutral, polar Cystein residue, which might affect disulfide bonds. In silico analysis predicts Arg204Cys is probably damaging to the protein structure/function. Nevertheless, the Arg204 residue is not well conserved, as a Cysteine residue is present at this position in horse. Also, no missense mutations in nearby codons have been reported in association with EDMD. With the clinical and molecular information available at this time, we cannot definitively determine if Arg204Cys is a disease-causing mutation or a rare benign variant. The variant is found in DCM panel(s). -

X-linked Emery-Dreifuss muscular dystrophy Uncertain:1
Sep 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 204 of the EMD protein (p.Arg204Cys). This variant is present in population databases (rs782299893, gnomAD 0.005%), including at least one homozygous and/or hemizygous individual. This variant has not been reported in the literature in individuals affected with EMD-related conditions. ClinVar contains an entry for this variant (Variation ID: 201776). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt EMD protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Cardiovascular phenotype Uncertain:1
Nov 22, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.R204C variant (also known as c.610C>T), located in coding exon 6 of the EMD gene, results from a C to T substitution at nucleotide position 610. The arginine at codon 204 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on data from gnomAD, the T allele has an overall frequency of 0.0024% (5/205035) total alleles studied, with 1 hemizygote(s) observed. The highest observed frequency was 0.0187% (1/5339) of Other alleles. Based on the available evidence, the clinical significance of this variant remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.34
BayesDel_addAF
Benign
-0.060
T
BayesDel_noAF
Benign
-0.21
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.87
D;T
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.82
T;T
M_CAP
Benign
0.085
D
MetaRNN
Benign
0.21
T;T
MetaSVM
Benign
-0.33
T
MutationAssessor
Benign
1.2
L;.
PhyloP100
1.1
PrimateAI
Uncertain
0.53
T
PROVEAN
Uncertain
-2.7
D;D
REVEL
Benign
0.19
Sift
Uncertain
0.0020
D;D
Sift4G
Pathogenic
0.0
D;D
Polyphen
0.029
B;.
Vest4
0.30
MutPred
0.53
Loss of MoRF binding (P = 0.0085);.;
MVP
0.77
MPC
0.38
ClinPred
0.19
T
GERP RS
2.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.21
gMVP
0.60
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs782299893; hg19: chrX-153609402; API